(Q54564470)

1 June 2018

title

Transplantation: mTOR inhibition in kidney transplant recipients. (English)

1 reference

1 June 2018

author name string

Sarah E Yost

series ordinal

1

1 reference

1 June 2018

Rochelle Byrne

series ordinal

2

1 reference

1 June 2018

Bruce Kaplan

series ordinal

3

1 reference

1 June 2018

language of work or name

English

0 references

publication date

30 August 2011

1 reference

1 June 2018

Nature Reviews Nephrology

published in

1 reference

1 June 2018

volume

7

1 reference

1 June 2018

issue

10

1 reference

1 June 2018

page(s)

553-555

1 reference

1 June 2018

Conversion of long-term kidney transplant recipients from calcineurin inhibitor therapy to everolimus: a randomized, multicenter, 24-month study.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

The ORION study: comparison of two sirolimus-based regimens versus tacrolimus and mycophenolate mofetil in renal allograft recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

Efficacy on renal function of early conversion from cyclosporine to sirolimus 3 months after renal transplantation: concept study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

Sirolimus Versus Cyclosporine in Kidney Recipients Receiving Thymoglobulin®, Mycophenolate Mofetil and a 6-Month Course of Steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

Lower malignancy rates in renal allograft recipients converted to sirolimus-based, calcineurin inhibitor-free immunotherapy: 24-month results from the CONVERT trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2011.125

21 January 2018

Identifiers

DOI

10.1038/NRNEPH.2011.125

1 reference

1 June 2018

1 reference

1 June 2018